LAGE3
EKC/KEOPS complex subunit LAGE3
Also known as: CVG5, DXS9879E, DXS9951E, ESO3, ITBA2, LAGE3_HUMAN, Pcc1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14657
- Gene
- LAGE3
- Ensembl
- ENSG00000196976
- Chromosome
- X
- Canonical length
- 143 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
This gene belongs to the ESO/LAGE gene family, members of which are clustered together on chromosome Xq28, and have similar exon-intron structures. Unlike the other family members which are normally expressed only in testis and activated in a wide range of human tumors, this gene is ubiquitously expressed in somatic tissues. The latter, combined with the finding that it is highly conserved in mouse and rat, suggests that the encoded protein is functionally important. An intronless pseudogene with high sequence similarity to this gene is located on chromosome 9. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
143 residues, UniProt reviewed canonical sequence.
>Q14657|LAGE3
1 MRDADADAGG GADGGDGRGG HSCRGGVDTA AAPAGGAPPA HAPGPGRDAA SAARGSRMRP
61 HIFTLSVPFP TPLEAEIAHG SLAPDAEPHQ RVVGKDLTVS GRILVVRWKA EDCRLLRISV
121 INFLDQLSLV VRTMQRFGPP VSRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LAGE3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 51 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 51 nTPM
- amygdala: 47 nTPM
- basal ganglia: 45 nTPM
- hippocampal formation: 43 nTPM
- midbrain: 33 nTPM
- pituitary gland: 32 nTPM
Single-cell type
- hofbauer cells: 186 nCPM
- epididymal principal cells: 160 nCPM
- megakaryocytes: 148 nCPM
- extravillous trophoblasts: 141 nCPM
- oocytes: 134 nCPM
- gastric progenitor cells: 124 nCPM
Immune cell
- naive CD4 T-cell: 81 nTPM
- plasmacytoid DC: 65 nTPM
- NK-cell: 46 nTPM
- naive CD8 T-cell: 41 nTPM
- memory B-cell: 40 nTPM
- total PBMC: 39 nTPM
Brain region
- cerebral cortex: 32 nTPM
- hippocampal formation: 31 nTPM
- white matter: 29 nTPM
- basal ganglia: 28 nTPM
- thalamus: 26 nTPM
- cerebellum: 25 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LAGE3.
Disease | AllUniProt
Conditions LAGE3 is implicated in, by any mechanism.
- Galloway-Mowat syndrome 2, X-linked (GAMOS2) MIM:301006
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 108 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Galloway-Mowat syndrome 2, X-linked
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.81
- gnomAD pLI
- 0.13
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- -0.32
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LAGE3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LAGE3 as an antibody target. Whether an autoantibody or antibody against LAGE3 could matter depends on whether native LAGE3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LAGE3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LAGE3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...